Home |
Free Dividend Report |
Stock Splits Calendar |
AGEN Historical Stock Prices |
Preferred Stock Newsletter |
AGEN Options Chain |
AGEN Message Board |
Agenus (AGEN) has the following price history information. Looking back at AGEN historical stock prices for the last five trading days, on April 22, 2024, AGEN opened at $5.40, traded as high as $5.85 and as low as $4.91, and closed at $5.77. Trading volume was a total of 900.30K shares. On April 23, 2024, AGEN opened at $5.76, traded as high as $7.51 and as low as $5.70, and closed at $6.46. Trading volume was a total of 1.69M shares. On April 24, 2024, AGEN opened at $6.84, traded as high as $7.74 and as low as $6.31, and closed at $7.42. Trading volume was a total of 1.27M shares. On April 25, 2024, AGEN opened at $7.35, traded as high as $8.47 and as low as $7.20, and closed at $8.30. Trading volume was a total of 961.40K shares. On April 26, 2024, AGEN opened at $8.60, traded as high as $12.23 and as low as $8.45, and closed at $11.69. Trading volume was a total of 3.35M shares.
AGEN Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Agenus shares, starting with a $10,000 purchase of AGEN, and working forward through the historical stock price information to today.
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 04/29/2014 | |
End date: | 04/26/2024 | |
Start price/share: | $57.80 | |
End price/share: | $11.69 | |
Dividends collected/share: | $0.00 | |
Total return: | -79.78% | |
Average Annual Total Return: | -14.77% | |
Starting investment: | $10,000.00 | |
Ending investment: | $2,022.67 | |
Years: | 10.00 |
AGEN Historical Price Range | |||||
Date | Open | High | Low | Close | Volume |
04/22/2024 | $5.40 | $5.85 | $4.91 | $5.77 | 900.30K |
04/23/2024 | $5.76 | $7.51 | $5.70 | $6.46 | 1.69M |
04/24/2024 | $6.84 | $7.74 | $6.31 | $7.42 | 1.27M |
04/25/2024 | $7.35 | $8.47 | $7.20 | $8.30 | 961.40K |
04/26/2024 | $8.60 | $12.23 | $8.45 | $11.69 | 3.35M |
About Agenus |
Agenus is a clinical-stage immuno-oncology (I-O) company engaged in the development of a pipeline of immune checkpoint antibodies, adoptive cell therapies and neoantigen cancer vaccines, to fight cancer and infections. Co.'s antibody candidates are balstilimab (an anti-PD-1 antibody) and zalifrelimab (an anti-CTLA-4 antibody), which are in Phase 2 trials as both a monotherapy (balstilimab) and combination therapy (balstilimab/zalifrelimab) for treatment of patients with second-line cervical cancer. Co. is also developing an anti-CTLA-4 antibody, botensilimab (also known as AGEN1181), which is designed to improve the magnitude of responses to first-generation anti-CTLA-4 molecules. |
AGEN Historical Closing Prices | |
Date | Close |
04/22/2024 | $5.77 |
04/23/2024 | $6.46 |
04/24/2024 | $7.42 |
04/25/2024 | $8.30 |
04/26/2024 | $11.69 |
Healthcare Historical Prices |
AGEN is categorized under the Healthcare sector; below are some other companies in the same sector:
AGIO Historical Stock Prices Also explore: AGEN shares outstanding history
Free AGEN Email Alerts:
|
AGEN Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.